Settlement Structure: Claims Made
Active: OpenCase Summary:
This is for those seeking compensation Purdue Pharma, LP, claiming harm from its actions or its opioids, such as OxyContin. Cases have been filed against Purdie and related companies, alleging that Purdue pushed its opioids excessively and deliberately underestimated their risks. Individuals are making claims for addiction and wrongful death, and even states have claimed harm from opioid addictions.
Purdue is currently in bankruptcy, and parties wanting compensation are not filling out the usual types of claim forms. Instead, the forms in this case will become part of the bankruptcy proceedings.
Because this is a bankruptcy proceeding and not a normal settlement, there is no settlement agreement or settlement administrator and no information on a total settlement amount, benefits to class members, or the like. Hearing dates are not currently available.
An Official Committee of Unsecured Creditors has been appointed to represent the interests of all unsecured creditors (that is, those who do not have any security or collateral securing the debts they are claiming are owed). To reach this committee, contact Kurztman Carson Consultants, the Information Agent for the Committee, at (888) 647-1738 (U.S./Canada) or (310) 751-2625 (International) or https://www.kccllc.net/purduecreditors/inquiry. You may also contact counsel to the Committee, Akin Gump Strauss Hauer & Feld LLP, at email@example.com.Docket Number:
Company: Purdue Pharma Inc.
Filing Deadline: June 30, 2020
Class Period: September 15, 2019Proof of Purchase:
See the applicable claim form and instructions to determine the documentation required to submit a claim. Also see the website as to which information will become part of the public record and which will be kept confidential.Eligibility:
You may be eligible if you believe you have been injured by Purdue, its general partner, its subsidiaries (including Therapeutics LP, Adlon Therapeutics LP, Greenfield BioVentures LP, Avrio Health LP, Rhodes Technologies, and Rhodes Pharmaceuticals LP) or Purdue prescription opioids, like OxyContin, or other prescription opioids made, sold, or marketed by Purdue, that arose before September 15, 2019, and for which you have not already been compensated. Claim forms are provided for non-opioid claimants, general opioid claimants, governmental opioid claimants, and personal injury claimants.
Claims may include wrongful-death claims filed on behalf of a deceased person’s estate and claims filed on behalf of a minor or baby.
Purdue Pharma (Canada), Purdue Frederick, Inc. (Canada), and Purdue Pharma, Inc. (Canada) are not part of this bankruptcy or the related class actions.Typical Settlement Amount:
NA. Note that this is not a conventional settlement. it is a bankruptcy case that is still in progress.
Total Settlement Amount: NAClass Representative Proposed Incentive Fee:
Case Name: Purdue Pharma, LP Chapter 11 Bankruptcy
Settlement Website: Purdue Bankruptcy and Filing of Opioid-Related Claims Website
Prime Clerk, LLC
Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
Grand Central Station, PO Box 4850
New York, NY 10163-4850